Leqembi, along with rare disease and depression treatments, helped offset a year-over-year decline in revenue for the company’s multiple sclerosis products.
Related Posts
Dozens of flights diverted, delayed after FAA warned of SpaceX rocket debris
Dozens of flights turned back to their original airport or were delayed after the FAA warned about debris from the latest SpaceX rocket launch.
23andMe appoints three new board members following abrupt resignations
23andMe appointed three new independent directors to its board, the company said Tuesday.
JetBlue fined $2 million by DOT for ‘chronically delayed flights’
The Department of Transportation said its $2 million fine against JetBlue was the first of its kind for chronically delayed flights.